Contract Research Outsourcing

Contract Research Outsourcing

Global Contract Research Outsourcing Market to Reach $72.1 Billion by 2027
In the changed post COVID-19 business landscape, the global market for Contract Research Outsourcing estimated at US$44.9 Billion in the year 2020, is projected to reach a revised size of US$72.1 Billion by 2027, growing at a CAGR of 7% over the analysis period 2020-2027. Clinical, one of the segments analyzed in the report, is projected to record a 7.4% CAGR and reach US$48.4 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Discovery segment is readjusted to a revised 6% CAGR for the next 7-year period.

The U.S. Market is Estimated at $18.1 Billion, While China is Forecast to Grow at 9.3% CAGR
The Contract Research Outsourcing market in the U.S. is estimated at US$18.1 Billion in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$4.2 Billion by the year 2027 trailing a CAGR of 9.3% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 6.1% and 6.2% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 6.7% CAGR.Pre-Clinical Segment to Record 6.8% CAGR
In the global Pre-Clinical segment, USA, Canada, Japan, China and Europe will drive the 6.8% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$5.3 Billion in the year 2020 will reach a projected size of US$8.2 Billion by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets.

Select Competitors (Total 152 Featured) -

  • Albany Molecular Research, Inc.
  • Charles River Laboratories International, Inc.
  • Covance Clinical Biotech
  • ICON plc
  • IQVIA Inc
  • Jubilant Biosys Ltd.
  • Laboratory Corporation of America® Holdings
  • Olon Ricerca Bioscience
  • PAREXEL International Corp.
  • Pharmaceutical Product Development, LLC.
  • Pharmaron
  • PRA Health Sciences, Inc.
  • Sygnature Discovery Limited
  • Syneos Health
  • SynteractHCR
  • WuXi AppTec
Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.

The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.

Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.


I. METHODOLOGY
II. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
Influencer Market Insights
World Market Trajectories
Impact of Covid-19 and a Looming Global Recession
COVID-19 Delivers Mixed Results for Pharmaceutical Research Outsourcing Industry
Players Focus on Collaborative Approach
Optimism Reigns in Latter Part of 2020
COVID-19 and Implications for Drug Development Regulations & Processes
Opportunities in COVID-19 Programs
Parallel Gains for Development & Manufacturing
Contract Research Outsourcing – Global Key Competitors Percentage Market Share in 2022 (E)
Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E)
Contract Research Outsourcing: An Introduction
Key Service Markets
Market Dynamics
Key Therapeutic Areas of Clinical Trial Research
Global Clinical Trial Services Market by Therapeutic Area: 2019
Top 6 Therapeutic Categories by Number of R&D Products in 2020
Cost Savings Hold Relevance
Product Innovations & Enhanced Speed
Access to Expertise & Sophisticated Technology
Outlook
Regional Market Analysis
Future Model of CRO
COMPETITIVE SCENARIO
CRO: A Highly Fragmented Market
Leading Players in the Global Contract Research Outsourcing Market (2019): Percentage Breakdown of Revenues by Player
Partnership Models Pay Returns
Strategies and Tactical Programs
Large CROs Seek the Inorganic Growth Route
Key Opportunities for CROs
Technological Superiority: An Advantage
Consolidation to Gain Pace
Recent Market Activity
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
Uptrend in Advanced Medicine Concepts Favors Growth
Drug Developers Bet on CROs to Sail through Challenging Aspects
Pharmaceutical & Biopharmaceutical Firms Target Outsourcing
Gene Therapy Offers Exciting Opportunities for CROs
COVID-19 Creates a Pause in Gene Therapy Market Growth
Gene Therapy Set to Witness Rapid Growth Post COVID-19
Global Gene Therapy Market in US$ Million for Years 2020, 2022, 2024, 2026
Increasing Significance of Biologic Drugs Supports Market Demand
Global Biologic Drugs Market Size (in US$ Billion) for the Years 2019, 2022 & 2025
COVID-19 Drives Strong Gains for Biologics Activity
Opportunities Rife in Early Stage Drug Development
Notable Trends in Pharma/Biopharma R&D Impacting CROs
Advances in Digital/Technology and its Impact on Clinical Development
Significant Strides Taken in the Sphere of Current Clinical Research
Data Quality Oversight (DQO) Undergoes Change
Pharmacovigilance Set to Grow
Artificial Intelligence and Machine Learning Gain Interest
Orphan Drugs to the Fore
CROs Adapt New Technologies to See More Business in Future
Streamlining Development of Novel Trial Designs
Industry Witnesses Increased Spend on R&D Outsourcing
Pharmaceutical R&D Spending Worldwide (USD Billion): 2015-2025
Percentage Breakdown of Total Number of Compounds in Pipeline by Phase for Pre-Clinical, Phase I, Phase II and Phase III: 2019
Focus on Enhancing Site Selection and Patient Enrollment
CROs Enter into Alliances to Improve Efficiencies
Adoption of Digital Technologies Gains Pace
Toxicology Services Gain Notable Attention
Pharma Companies Enter into Licensing Agreements with Biotech Companies for New Drug Discovery
Pharmaceutical & Biopharmaceutical Trends to Support CRO Penetration
Global Biopharma % R&D Outsourcing (2014-2022)
New FDA Drug Approvals (2010-2016): Breakdown of Number of Approvals by Type for New Molecular Entity (NME) and Biologic License Application (BLA) Approvals
eClinical Solutions Gain Traction
Other Noteworthy Market Trends
Challenges Faced by Contract Research Organizations
Surging Global Population Offers Increased Growth Opportunities
World Population (in Thousands) by Geographic Region for the Years 2018, 2025, 2040, 2050
Aging Population & Increasing Burden of Chronic Diseases Spurs Pharma Product Sales, Driving Market Growth
Global Aging Population Statistics for the 65+ Age Group in Million by Geographic Region for the Years 2019, 2025, 2035 and 2050
Global Cancer Incidence: Number of New Cancer Cases in Million for the Years 2018, 2020, 2025, 2030, 2035 and 2040
Global Annual Medical Cost of CVD in US$ Billion (2010-2030)
Fatalities by Heart Conditions: Estimated Percentage Breakdown for Cardiovascular Disease, Ischemic Heart Disease, Stroke, and Others
World Diabetes and Population Statistics (2019, 2030 & 2045)
Increasing Healthcare Expenditure and Demand for Generics to Drive Growth
World Healthcare Expenditure (In US$ Billion) for the Years 2017-2023
EXHIBIT Healthcare Costs as a % of GDP by Country for the Years 2020 & 2023
4. GLOBAL MARKET PERSPECTIVE
TABLE 1: World Recent Past, Current & Future Analysis for Contract Research Outsourcing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2020 through 2027 and % CAGR
TABLE 2: World Historic Review for Contract Research Outsourcing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 3: World 15-Year Perspective for Contract Research Outsourcing by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets for Years 2012, 2021 & 2027
TABLE 4: World Recent Past, Current & Future Analysis for Clinical by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2020 through 2027 and % CAGR
TABLE 5: World Historic Review for Clinical by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 6: World 15-Year Perspective for Clinical by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World for Years 2012, 2021 & 2027
TABLE 7: World Recent Past, Current & Future Analysis for Discovery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2020 through 2027 and % CAGR
TABLE 8: World Historic Review for Discovery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 9: World 15-Year Perspective for Discovery by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World for Years 2012, 2021 & 2027
TABLE 10: World Recent Past, Current & Future Analysis for Pre-Clinical by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2020 through 2027 and % CAGR
TABLE 11: World Historic Review for Pre-Clinical by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 12: World 15-Year Perspective for Pre-Clinical by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World for Years 2012, 2021 & 2027
TABLE 13: World Recent Past, Current & Future Analysis for Laboratory Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2020 through 2027 and % CAGR
TABLE 14: World Historic Review for Laboratory Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 15: World 15-Year Perspective for Laboratory Services by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World for Years 2012, 2021 & 2027
TABLE 16: World Recent Past, Current & Future Analysis for Pharmaceutical & Biopharmaceutical Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2020 through 2027 and % CAGR
TABLE 17: World Historic Review for Pharmaceutical & Biopharmaceutical Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 18: World 15-Year Perspective for Pharmaceutical & Biopharmaceutical Companies by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World for Years 2012, 2021 & 2027
TABLE 19: World Recent Past, Current & Future Analysis for Medical Device Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2020 through 2027 and % CAGR
TABLE 20: World Historic Review for Medical Device Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 21: World 15-Year Perspective for Medical Device Companies by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World for Years 2012, 2021 & 2027
TABLE 22: World Recent Past, Current & Future Analysis for Academic Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2020 through 2027 and % CAGR
TABLE 23: World Historic Review for Academic Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 24: World 15-Year Perspective for Academic Institutes by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World for Years 2012, 2021 & 2027
III. MARKET ANALYSIS
UNITED STATES
Contract Research Outsourcing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2022 (E)
Market Overview
COVID-19 Pandemic: Mixed Bag of Opportunities for CROs
Drug Developers Rely on CROs to Improve Trial Efficiency and Cost Savings
Trial Services Witness Strong Demand
High Demand for Data Management Services
Risk-based Monitoring Catches Pace
Market Analytics
TABLE 25: USA Recent Past, Current & Future Analysis for Contract Research Outsourcing by Service Type - Clinical, Discovery, Pre-Clinical and Laboratory Services - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027 and % CAGR
TABLE 26: USA Historic Review for Contract Research Outsourcing by Service Type - Clinical, Discovery, Pre-Clinical and Laboratory Services Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 27: USA 15-Year Perspective for Contract Research Outsourcing by Service Type - Percentage Breakdown of Value Revenues for Clinical, Discovery, Pre-Clinical and Laboratory Services for the Years 2012, 2021 & 2027
TABLE 28: USA Recent Past, Current & Future Analysis for Contract Research Outsourcing by End-Use - Pharmaceutical & Biopharmaceutical Companies, Medical Device Companies and Academic Institutes - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027 and % CAGR
TABLE 29: USA Historic Review for Contract Research Outsourcing by End-Use - Pharmaceutical & Biopharmaceutical Companies, Medical Device Companies and Academic Institutes Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 30: USA 15-Year Perspective for Contract Research Outsourcing by End-Use - Percentage Breakdown of Value Revenues for Pharmaceutical & Biopharmaceutical Companies, Medical Device Companies and Academic Institutes for the Years 2012, 2021 & 2027
CANADA
TABLE 31: Canada Recent Past, Current & Future Analysis for Contract Research Outsourcing by Service Type - Clinical, Discovery, Pre-Clinical and Laboratory Services - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027 and % CAGR
TABLE 32: Canada Historic Review for Contract Research Outsourcing by Service Type - Clinical, Discovery, Pre-Clinical and Laboratory Services Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 33: Canada 15-Year Perspective for Contract Research Outsourcing by Service Type - Percentage Breakdown of Value Revenues for Clinical, Discovery, Pre-Clinical and Laboratory Services for the Years 2012, 2021 & 2027
TABLE 34: Canada Recent Past, Current & Future Analysis for Contract Research Outsourcing by End-Use - Pharmaceutical & Biopharmaceutical Companies, Medical Device Companies and Academic Institutes - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027 and % CAGR
TABLE 35: Canada Historic Review for Contract Research Outsourcing by End-Use - Pharmaceutical & Biopharmaceutical Companies, Medical Device Companies and Academic Institutes Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 36: Canada 15-Year Perspective for Contract Research Outsourcing by End-Use - Percentage Breakdown of Value Revenues for Pharmaceutical & Biopharmaceutical Companies, Medical Device Companies and Academic Institutes for the Years 2012, 2021 & 2027
JAPAN
Contract Research Outsourcing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2022 (E)
TABLE 37: Japan Recent Past, Current & Future Analysis for Contract Research Outsourcing by Service Type - Clinical, Discovery, Pre-Clinical and Laboratory Services - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027 and % CAGR
TABLE 38: Japan Historic Review for Contract Research Outsourcing by Service Type - Clinical, Discovery, Pre-Clinical and Laboratory Services Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 39: Japan 15-Year Perspective for Contract Research Outsourcing by Service Type - Percentage Breakdown of Value Revenues for Clinical, Discovery, Pre-Clinical and Laboratory Services for the Years 2012, 2021 & 2027
TABLE 40: Japan Recent Past, Current & Future Analysis for Contract Research Outsourcing by End-Use - Pharmaceutical & Biopharmaceutical Companies, Medical Device Companies and Academic Institutes - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027 and % CAGR
TABLE 41: Japan Historic Review for Contract Research Outsourcing by End-Use - Pharmaceutical & Biopharmaceutical Companies, Medical Device Companies and Academic Institutes Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 42: Japan 15-Year Perspective for Contract Research Outsourcing by End-Use - Percentage Breakdown of Value Revenues for Pharmaceutical & Biopharmaceutical Companies, Medical Device Companies and Academic Institutes for the Years 2012, 2021 & 2027
CHINA
Contract Research Outsourcing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2022 (E)
Market Overview
TABLE 43: China Recent Past, Current & Future Analysis for Contract Research Outsourcing by Service Type - Clinical, Discovery, Pre-Clinical and Laboratory Services - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027 and % CAGR
TABLE 44: China Historic Review for Contract Research Outsourcing by Service Type - Clinical, Discovery, Pre-Clinical and Laboratory Services Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 45: China 15-Year Perspective for Contract Research Outsourcing by Service Type - Percentage Breakdown of Value Revenues for Clinical, Discovery, Pre-Clinical and Laboratory Services for the Years 2012, 2021 & 2027
TABLE 46: China Recent Past, Current & Future Analysis for Contract Research Outsourcing by End-Use - Pharmaceutical & Biopharmaceutical Companies, Medical Device Companies and Academic Institutes - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027 and % CAGR
TABLE 47: China Historic Review for Contract Research Outsourcing by End-Use - Pharmaceutical & Biopharmaceutical Companies, Medical Device Companies and Academic Institutes Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 48: China 15-Year Perspective for Contract Research Outsourcing by End-Use - Percentage Breakdown of Value Revenues for Pharmaceutical & Biopharmaceutical Companies, Medical Device Companies and Academic Institutes for the Years 2012, 2021 & 2027
EUROPE
Contract Research Outsourcing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2022 (E)
Market Overview
Amid Pandemic, CRO Industry in Europe Gears Up for Broad-based Amendments
Providers Expand Services in Downstream Drug Development
Market Analytics
TABLE 49: Europe Recent Past, Current & Future Analysis for Contract Research Outsourcing by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2020 through 2027 and % CAGR
TABLE 50: Europe Historic Review for Contract Research Outsourcing by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 51: Europe 15-Year Perspective for Contract Research Outsourcing by Geographic Region - Percentage Breakdown of Value Revenues for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2012, 2021 & 2027
TABLE 52: Europe Recent Past, Current & Future Analysis for Contract Research Outsourcing by Service Type - Clinical, Discovery, Pre-Clinical and Laboratory Services - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027 and % CAGR
TABLE 53: Europe Historic Review for Contract Research Outsourcing by Service Type - Clinical, Discovery, Pre-Clinical and Laboratory Services Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 54: Europe 15-Year Perspective for Contract Research Outsourcing by Service Type - Percentage Breakdown of Value Revenues for Clinical, Discovery, Pre-Clinical and Laboratory Services for the Years 2012, 2021 & 2027
TABLE 55: Europe Recent Past, Current & Future Analysis for Contract Research Outsourcing by End-Use - Pharmaceutical & Biopharmaceutical Companies, Medical Device Companies and Academic Institutes - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027 and % CAGR
TABLE 56: Europe Historic Review for Contract Research Outsourcing by End-Use - Pharmaceutical & Biopharmaceutical Companies, Medical Device Companies and Academic Institutes Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 57: Europe 15-Year Perspective for Contract Research Outsourcing by End-Use - Percentage Breakdown of Value Revenues for Pharmaceutical & Biopharmaceutical Companies, Medical Device Companies and Academic Institutes for the Years 2012, 2021 & 2027
FRANCE
Contract Research Outsourcing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2022 (E)
TABLE 58: France Recent Past, Current & Future Analysis for Contract Research Outsourcing by Service Type - Clinical, Discovery, Pre-Clinical and Laboratory Services - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027 and % CAGR
TABLE 59: France Historic Review for Contract Research Outsourcing by Service Type - Clinical, Discovery, Pre-Clinical and Laboratory Services Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 60: France 15-Year Perspective for Contract Research Outsourcing by Service Type - Percentage Breakdown of Value Revenues for Clinical, Discovery, Pre-Clinical and Laboratory Services for the Years 2012, 2021 & 2027
TABLE 61: France Recent Past, Current & Future Analysis for Contract Research Outsourcing by End-Use - Pharmaceutical & Biopharmaceutical Companies, Medical Device Companies and Academic Institutes - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027 and % CAGR
TABLE 62: France Historic Review for Contract Research Outsourcing by End-Use - Pharmaceutical & Biopharmaceutical Companies, Medical Device Companies and Academic Institutes Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 63: France 15-Year Perspective for Contract Research Outsourcing by End-Use - Percentage Breakdown of Value Revenues for Pharmaceutical & Biopharmaceutical Companies, Medical Device Companies and Academic Institutes for the Years 2012, 2021 & 2027
GERMANY
Contract Research Outsourcing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2022 (E)
TABLE 64: Germany Recent Past, Current & Future Analysis for Contract Research Outsourcing by Service Type - Clinical, Discovery, Pre-Clinical and Laboratory Services - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027 and % CAGR
TABLE 65: Germany Historic Review for Contract Research Outsourcing by Service Type - Clinical, Discovery, Pre-Clinical and Laboratory Services Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 66: Germany 15-Year Perspective for Contract Research Outsourcing by Service Type - Percentage Breakdown of Value Revenues for Clinical, Discovery, Pre-Clinical and Laboratory Services for the Years 2012, 2021 & 2027
TABLE 67: Germany Recent Past, Current & Future Analysis for Contract Research Outsourcing by End-Use - Pharmaceutical & Biopharmaceutical Companies, Medical Device Companies and Academic Institutes - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027 and % CAGR
TABLE 68: Germany Historic Review for Contract Research Outsourcing by End-Use - Pharmaceutical & Biopharmaceutical Companies, Medical Device Companies and Academic Institutes Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 69: Germany 15-Year Perspective for Contract Research Outsourcing by End-Use - Percentage Breakdown of Value Revenues for Pharmaceutical & Biopharmaceutical Companies, Medical Device Companies and Academic Institutes for the Years 2012, 2021 & 2027
ITALY
TABLE 70: Italy Recent Past, Current & Future Analysis for Contract Research Outsourcing by Service Type - Clinical, Discovery, Pre-Clinical and Laboratory Services - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027 and % CAGR
TABLE 71: Italy Historic Review for Contract Research Outsourcing by Service Type - Clinical, Discovery, Pre-Clinical and Laboratory Services Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 72: Italy 15-Year Perspective for Contract Research Outsourcing by Service Type - Percentage Breakdown of Value Revenues for Clinical, Discovery, Pre-Clinical and Laboratory Services for the Years 2012, 2021 & 2027
TABLE 73: Italy Recent Past, Current & Future Analysis for Contract Research Outsourcing by End-Use - Pharmaceutical & Biopharmaceutical Companies, Medical Device Companies and Academic Institutes - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027 and % CAGR
TABLE 74: Italy Historic Review for Contract Research Outsourcing by End-Use - Pharmaceutical & Biopharmaceutical Companies, Medical Device Companies and Academic Institutes Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 75: Italy 15-Year Perspective for Contract Research Outsourcing by End-Use - Percentage Breakdown of Value Revenues for Pharmaceutical & Biopharmaceutical Companies, Medical Device Companies and Academic Institutes for the Years 2012, 2021 & 2027
UNITED KINGDOM
Contract Research Outsourcing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2022 (E)
TABLE 76: UK Recent Past, Current & Future Analysis for Contract Research Outsourcing by Service Type - Clinical, Discovery, Pre-Clinical and Laboratory Services - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027 and % CAGR
TABLE 77: UK Historic Review for Contract Research Outsourcing by Service Type - Clinical, Discovery, Pre-Clinical and Laboratory Services Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 78: UK 15-Year Perspective for Contract Research Outsourcing by Service Type - Percentage Breakdown of Value Revenues for Clinical, Discovery, Pre-Clinical and Laboratory Services for the Years 2012, 2021 & 2027
TABLE 79: UK Recent Past, Current & Future Analysis for Contract Research Outsourcing by End-Use - Pharmaceutical & Biopharmaceutical Companies, Medical Device Companies and Academic Institutes - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027 and % CAGR
TABLE 80: UK Historic Review for Contract Research Outsourcing by End-Use - Pharmaceutical & Biopharmaceutical Companies, Medical Device Companies and Academic Institutes Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 81: UK 15-Year Perspective for Contract Research Outsourcing by End-Use - Percentage Breakdown of Value Revenues for Pharmaceutical & Biopharmaceutical Companies, Medical Device Companies and Academic Institutes for the Years 2012, 2021 & 2027
SPAIN
TABLE 82: Spain Recent Past, Current & Future Analysis for Contract Research Outsourcing by Service Type - Clinical, Discovery, Pre-Clinical and Laboratory Services - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027 and % CAGR
TABLE 83: Spain Historic Review for Contract Research Outsourcing by Service Type - Clinical, Discovery, Pre-Clinical and Laboratory Services Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 84: Spain 15-Year Perspective for Contract Research Outsourcing by Service Type - Percentage Breakdown of Value Revenues for Clinical, Discovery, Pre-Clinical and Laboratory Services for the Years 2012, 2021 & 2027
TABLE 85: Spain Recent Past, Current & Future Analysis for Contract Research Outsourcing by End-Use - Pharmaceutical & Biopharmaceutical Companies, Medical Device Companies and Academic Institutes - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027 and % CAGR
TABLE 86: Spain Historic Review for Contract Research Outsourcing by End-Use - Pharmaceutical & Biopharmaceutical Companies, Medical Device Companies and Academic Institutes Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 87: Spain 15-Year Perspective for Contract Research Outsourcing by End-Use - Percentage Breakdown of Value Revenues for Pharmaceutical & Biopharmaceutical Companies, Medical Device Companies and Academic Institutes for the Years 2012, 2021 & 2027
RUSSIA
TABLE 88: Russia Recent Past, Current & Future Analysis for Contract Research Outsourcing by Service Type - Clinical, Discovery, Pre-Clinical and Laboratory Services - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027 and % CAGR
TABLE 89: Russia Historic Review for Contract Research Outsourcing by Service Type - Clinical, Discovery, Pre-Clinical and Laboratory Services Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 90: Russia 15-Year Perspective for Contract Research Outsourcing by Service Type - Percentage Breakdown of Value Revenues for Clinical, Discovery, Pre-Clinical and Laboratory Services for the Years 2012, 2021 & 2027
TABLE 91: Russia Recent Past, Current & Future Analysis for Contract Research Outsourcing by End-Use - Pharmaceutical & Biopharmaceutical Companies, Medical Device Companies and Academic Institutes - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027 and % CAGR
TABLE 92: Russia Historic Review for Contract Research Outsourcing by End-Use - Pharmaceutical & Biopharmaceutical Companies, Medical Device Companies and Academic Institutes Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 93: Russia 15-Year Perspective for Contract Research Outsourcing by End-Use - Percentage Breakdown of Value Revenues for Pharmaceutical & Biopharmaceutical Companies, Medical Device Companies and Academic Institutes for the Years 2012, 2021 & 2027
REST OF EUROPE
TABLE 94: Rest of Europe Recent Past, Current & Future Analysis for Contract Research Outsourcing by Service Type - Clinical, Discovery, Pre-Clinical and Laboratory Services - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027 and % CAGR
TABLE 95: Rest of Europe Historic Review for Contract Research Outsourcing by Service Type - Clinical, Discovery, Pre-Clinical and Laboratory Services Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 96: Rest of Europe 15-Year Perspective for Contract Research Outsourcing by Service Type - Percentage Breakdown of Value Revenues for Clinical, Discovery, Pre-Clinical and Laboratory Services for the Years 2012, 2021 & 2027
TABLE 97: Rest of Europe Recent Past, Current & Future Analysis for Contract Research Outsourcing by End-Use - Pharmaceutical & Biopharmaceutical Companies, Medical Device Companies and Academic Institutes - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027 and % CAGR
TABLE 98: Rest of Europe Historic Review for Contract Research Outsourcing by End-Use - Pharmaceutical & Biopharmaceutical Companies, Medical Device Companies and Academic Institutes Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 99: Rest of Europe 15-Year Perspective for Contract Research Outsourcing by End-Use - Percentage Breakdown of Value Revenues for Pharmaceutical & Biopharmaceutical Companies, Medical Device Companies and Academic Institutes for the Years 2012, 2021 & 2027
ASIA-PACIFIC
Contract Research Outsourcing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2022 (E)
Market Overview
Asia-Pacific to Push Up Volume Share in CRO Market
R&D Outsourcing in Life Sciences on Rise
Market Analytics
TABLE 100: Asia-Pacific Recent Past, Current & Future Analysis for Contract Research Outsourcing by Geographic Region - India and Rest of Asia-Pacific Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2020 through 2027 and % CAGR
TABLE 101: Asia-Pacific Historic Review for Contract Research Outsourcing by Geographic Region - India and Rest of Asia-Pacific Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 102: Asia-Pacific 15-Year Perspective for Contract Research Outsourcing by Geographic Region - Percentage Breakdown of Value Revenues for India and Rest of Asia-Pacific Markets for Years 2012, 2021 & 2027
TABLE 103: Asia-Pacific Recent Past, Current & Future Analysis for Contract Research Outsourcing by Service Type - Clinical, Discovery, Pre-Clinical and Laboratory Services - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027 and % CAGR
TABLE 104: Asia-Pacific Historic Review for Contract Research Outsourcing by Service Type - Clinical, Discovery, Pre-Clinical and Laboratory Services Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 105: Asia-Pacific 15-Year Perspective for Contract Research Outsourcing by Service Type - Percentage Breakdown of Value Revenues for Clinical, Discovery, Pre-Clinical and Laboratory Services for the Years 2012, 2021 & 2027
TABLE 106: Asia-Pacific Recent Past, Current & Future Analysis for Contract Research Outsourcing by End-Use - Pharmaceutical & Biopharmaceutical Companies, Medical Device Companies and Academic Institutes - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027 and % CAGR
TABLE 107: Asia-Pacific Historic Review for Contract Research Outsourcing by End-Use - Pharmaceutical & Biopharmaceutical Companies, Medical Device Companies and Academic Institutes Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 108: Asia-Pacific 15-Year Perspective for Contract Research Outsourcing by End-Use - Percentage Breakdown of Value Revenues for Pharmaceutical & Biopharmaceutical Companies, Medical Device Companies and Academic Institutes for the Years 2012, 2021 & 2027
INDIA
Contract Research Outsourcing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2022 (E)
Indian CROs Seek Opportunities
TABLE 109: India Recent Past, Current & Future Analysis for Contract Research Outsourcing by Service Type - Clinical, Discovery, Pre-Clinical and Laboratory Services - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027 and % CAGR
TABLE 110: India Historic Review for Contract Research Outsourcing by Service Type - Clinical, Discovery, Pre-Clinical and Laboratory Services Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 111: India 15-Year Perspective for Contract Research Outsourcing by Service Type - Percentage Breakdown of Value Revenues for Clinical, Discovery, Pre-Clinical and Laboratory Services for the Years 2012, 2021 & 2027
TABLE 112: India Recent Past, Current & Future Analysis for Contract Research Outsourcing by End-Use - Pharmaceutical & Biopharmaceutical Companies, Medical Device Companies and Academic Institutes - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027 and % CAGR
TABLE 113: India Historic Review for Contract Research Outsourcing by End-Use - Pharmaceutical & Biopharmaceutical Companies, Medical Device Companies and Academic Institutes Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 114: India 15-Year Perspective for Contract Research Outsourcing by End-Use - Percentage Breakdown of Value Revenues for Pharmaceutical & Biopharmaceutical Companies, Medical Device Companies and Academic Institutes for the Years 2012, 2021 & 2027
REST OF ASIA-PACIFIC
Market Overview
Australia: Popular Destination for Early Phase Clinical Trials
Market Analytics
TABLE 115: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Contract Research Outsourcing by Service Type - Clinical, Discovery, Pre-Clinical and Laboratory Services - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027 and % CAGR
TABLE 116: Rest of Asia-Pacific Historic Review for Contract Research Outsourcing by Service Type - Clinical, Discovery, Pre-Clinical and Laboratory Services Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 117: Rest of Asia-Pacific 15-Year Perspective for Contract Research Outsourcing by Service Type - Percentage Breakdown of Value Revenues for Clinical, Discovery, Pre-Clinical and Laboratory Services for the Years 2012, 2021 & 2027
TABLE 118: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Contract Research Outsourcing by End-Use - Pharmaceutical & Biopharmaceutical Companies, Medical Device Companies and Academic Institutes - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027 and % CAGR
TABLE 119: Rest of Asia-Pacific Historic Review for Contract Research Outsourcing by End-Use - Pharmaceutical & Biopharmaceutical Companies, Medical Device Companies and Academic Institutes Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 120: Rest of Asia-Pacific 15-Year Perspective for Contract Research Outsourcing by End-Use - Percentage Breakdown of Value Revenues for Pharmaceutical & Biopharmaceutical Companies, Medical Device Companies and Academic Institutes for the Years 2012, 2021 & 2027
LATIN AMERICA
Contract Research Outsourcing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2022 (E)
TABLE 121: Latin America Recent Past, Current & Future Analysis for Contract Research Outsourcing by Service Type - Clinical, Discovery, Pre-Clinical and Laboratory Services - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027 and % CAGR
TABLE 122: Latin America Historic Review for Contract Research Outsourcing by Service Type - Clinical, Discovery, Pre-Clinical and Laboratory Services Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 123: Latin America 15-Year Perspective for Contract Research Outsourcing by Service Type - Percentage Breakdown of Value Revenues for Clinical, Discovery, Pre-Clinical and Laboratory Services for the Years 2012, 2021 & 2027
TABLE 124: Latin America Recent Past, Current & Future Analysis for Contract Research Outsourcing by End-Use - Pharmaceutical & Biopharmaceutical Companies, Medical Device Companies and Academic Institutes - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027 and % CAGR
TABLE 125: Latin America Historic Review for Contract Research Outsourcing by End-Use - Pharmaceutical & Biopharmaceutical Companies, Medical Device Companies and Academic Institutes Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 126: Latin America 15-Year Perspective for Contract Research Outsourcing by End-Use - Percentage Breakdown of Value Revenues for Pharmaceutical & Biopharmaceutical Companies, Medical Device Companies and Academic Institutes for the Years 2012, 2021 & 2027
REST OF WORLD
TABLE 127: Rest of World Recent Past, Current & Future Analysis for Contract Research Outsourcing by Service Type - Clinical, Discovery, Pre-Clinical and Laboratory Services - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027 and % CAGR
TABLE 128: Rest of World Historic Review for Contract Research Outsourcing by Service Type - Clinical, Discovery, Pre-Clinical and Laboratory Services Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 129: Rest of World 15-Year Perspective for Contract Research Outsourcing by Service Type - Percentage Breakdown of Value Revenues for Clinical, Discovery, Pre-Clinical and Laboratory Services for the Years 2012, 2021 & 2027
TABLE 130: Rest of World Recent Past, Current & Future Analysis for Contract Research Outsourcing by End-Use - Pharmaceutical & Biopharmaceutical Companies, Medical Device Companies and Academic Institutes - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027 and % CAGR
TABLE 131: Rest of World Historic Review for Contract Research Outsourcing by End-Use - Pharmaceutical & Biopharmaceutical Companies, Medical Device Companies and Academic Institutes Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 132: Rest of World 15-Year Perspective for Contract Research Outsourcing by End-Use - Percentage Breakdown of Value Revenues for Pharmaceutical & Biopharmaceutical Companies, Medical Device Companies and Academic Institutes for the Years 2012, 2021 & 2027
IV. COMPETITION
Total Companies Profiled: 152

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings